Does a test that is more sensitive, provide faster turnaround time, and more accurate determine susceptibility make a clinical difference?

We investigated this very question by retrospectively reviewing the hospitalization/ED visit rate of 66,383 patients who were either treated against Standard Urine Culture or Guidance-UTI. The cohort which was treated using Guidance UTI illustrated a 13.7% drop in hospitalization/ED visits relative to the other cohort.